Tag Archives | DaVita
The DaVita 2018 annual meeting is June 18. Vote AGAINST Arway, Desroches, Grauer and Thiry, as well as pay. Vote FOR proxy access amendments to enhance long-term shareholder value. Continue Reading →
DaVita HealthCare Partners Inc (NYSE:DVA), one of the companies in my portfolio, provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. Their annual meeting is coming up on June 20, 2016. I have a proposal on the proxy to allow shareholders to act by written consent.
ProxyDemocracy.org had collected the votes of three fund families when I checked. Vote AGAINST pay, committee, and proxy access ‘lite’; FOR the right to act by written consent. I voted with the Board’s recommendations 53% of the time. View Proxy Statement via iiWisdom.
DaVita ($DVA) is one of the stocks in my portfolio. Their annual meeting is coming up on 6/11/2012. Voting ends 6/8 at 5 am ET on Moxy Vote’s proxy voting platform (early because of the weekend), which had 3 recommendations “from good causes” when I checked and voted on 6/6/2012. However, two were consolidations, so they really only had recommendations from Calvert. ProxyDemocracy.org had information on 4 funds voting. I voted with management 54% of the time. Continue Reading →
WorldBlu looks at this important issue within a long series aimed at implementing democracy in the workplace. This segment looks at DaVita, a FORTUNE 500 company comprised of 35,000 employees with nearly $6 billion in annual revenue. It is the largest independent provider of dialysis services in the United States, operating over 1300 clinics.
On a regular basis, DaVita teammates are asked to vote on various aspects of the company, including program names and logos, new practices, and initiatives being considered for the upcoming year. DaVita’s Chairman and CEO, Kent Thiry, explains “At DaVita, we are truly a community first and a company second.” (Disclosure: James McRitchie, CorpGov.net Publisher, is a DiVita shareowner.)